| A Trial of Ribocilcib (LEE011) and Weekly Paclitaxel in Patients With Rb+ Advanced Breast Cancer (NCT02599363) | Abramson Cancer Center at Penn Medicine | 2016-01-01 |
| AiDing Diuresis wIth Tolvaptan (ADD-IT) (NCT02646540) | Emory University | 2016-01-01 |
| Trail Evaluating Carbon Ion Radiotherapy (3 GyE Per Fraction) for Locally Recurrent Nasopharyngeal Carcinoma (NCT02795195) | Shanghai Proton and Heavy Ion Center | 2016-01-01 |
| A Phase I, Double Blind, Placebo Controlled, First in Human, Single and Multiple Ascending Oral Dose, Safety, Tolerability and Pharmacokinetic Study in Healthy Male and Female Subjects (NCT02639221) | Prexton Therapeutics | 2016-01-01 |
| Human Umbilical Cord-Mesenchymal Stem Cells for Rheumatoid Arthritis (NCT02643823) | Shenzhen Hornetcorn Bio-technology Company, LTD | 2016-01-01 |
| SLM + Axitinib for Clear Cell RCC (NCT02535533) | Mohammed Milhem | 2016-01-01 |
| A Study to Evaluate Abuse Potential of Istradefylline (NCT02609477) | Kyowa Kirin Co., Ltd. | 2016-01-01 |
| ASIS for Enbrel in Plaque Psoriasis (NCT02112097) | ASIS Corporation | 2016-01-01 |
| A Study to Evaluate the Pharmacokinetics Of Sativex® in Subjects With Severe Renal Impairment or End Stage Renal Disease, Compared to Matched Subjects With Normal Renal Function. (NCT02325024) | GW Pharmaceuticals Ltd | 2016-01-01 |
| Stem Cell Therapy Combined With NeuroRegen Scaffold™ in Patients With Erectile Dysfunction After Rectal Cancer Surgery (NCT02648386) | Chinese Academy of Sciences | 2016-01-01 |
| Safety and Tolerability of TAR-200 mg in Subjects With Non-Muscle-Invasive Bladder Cancer (NCT02720367) | Taris Biomedical LLC | 2016-01-01 |
| A Study to Evaluate the Effect of JNJ-63623872 on Cardiac Repolarization Interval in Healthy Participants (NCT02658825) | Janssen Research & Development, LLC | 2016-01-01 |
| ASIS for Botox in Chronic Migraine (NCT02074163) | ASIS Corporation | 2016-01-01 |
| Radiochemotherapy With Panitumumab in the Localised Epidermoid Carcinoma of the Anus (NCT01581840) | Federation Francophone de Cancerologie Digestive | 2016-01-01 |
| Clinical Bioequivalence Study on Two Gliclazide 80mg Tablet Formulations (NCT02643329) | Bright Future Pharmaceuticals Factory O/B Bright Future Pharmaceutical Laboratories Limited | 2016-01-01 |
| Safety of Escalating Doses of Intravenous Bone Marrow-Derived Mesenchymal Stem Cells in Patients With a New Ischemic Stroke (NCT01849887) | University of California, Irvine | 2016-01-01 |
| The Safety and Tolerability of Intra-abdominal t-PA and DNase on Peritonitis in Peritoneal Dialysis Patients (NCT01478698) | Sir Charles Gairdner Hospital | 2016-01-01 |
| Pharmacokinetics and Pharmacodynamics of RPH-104 in Healthy Subjects (NCT02667639) | R-Pharm | 2016-01-01 |
| A Study of PF-06410293 Following Subcutaneous Administration Using A Prefilled Syringe Or A Prefilled Pen In Healthy Adult Subjects (NCT02572245) | Pfizer | 2016-01-01 |
| Pembrolizumab in Patients Failing to Respond to or Relapsing After CAR T Cell Therapy for Relapsed or Refractory Lymphomas (NCT02650999) | Abramson Cancer Center at Penn Medicine | 2016-01-01 |
| PK/PD and Safety/Tolerability of Two Dosing Regimens of Oral Fosfomycin Tromethamine in Healthy Adults (NCT02570074) | Vance Fowler, M.D. | 2016-01-01 |
| A Tolerability and Pharmacokinetics Study of SHR6390 in Advanced Melanoma Patients (NCT02671513) | Jiangsu HengRui Medicine Co., Ltd. | 2016-01-01 |
| A Safety and Dose-Determining Study of CMX001 In Infants With Neonatal Herpes Simplex Virus (HSV) Infection Involving the Central Nervous System (CNS Disease) (NCT01610765) | University of Alabama at Birmingham | 2016-01-01 |
| Study of the Safety, Tolerability and Efficacy of KPT-8602 in Participants With Relapsed/Refractory Cancer Indications (NCT02649790) | Karyopharm Therapeutics Inc | 2016-01-01 |
| Assessment of Pharmacokinetics and Safety of M923 Administered Via Auto-injector or Prefilled Syringe, in Healthy Subjects (NCT02675023) | Momenta Pharmaceuticals, Inc. | 2016-01-01 |
| Autologous EBV-specific Cytotoxic T Cells for the Treatment of Systemic Lupus Erythematosus (SLE) (NCT02677688) | Nantes University Hospital | 2016-01-01 |
| ABC-08: Phase Ib Trial of Acelarin in Combination With Cisplatin in Locally Advanced/ Metastatic Biliary Tract Cancers (NCT02351765) | The Christie NHS Foundation Trust | 2016-01-01 |
| Clinical Study to Evaluate Z7200 Pharmacokinetics Profile (NCT02631941) | Zambon SpA | 2016-01-01 |
| Hysteroscopic Tubal Occlusion With the Use of Iso Amyl-2-cyanoacrylate (NCT02698644) | Ain Shams University | 2016-01-01 |
| Study to Evaluate Properties of Radiprodil Given in Oral Solution to Healthy Volunteers (NCT02647697) | UCB Biopharma S.P.R.L. | 2016-01-01 |
| PTCy and Ruxolitinib GVHD Prophylaxis in Myelofibrosis (NCT02806375) | St. Petersburg State Pavlov Medical University | 2016-01-01 |
| Study of DWJ1351 in Healthy Male Volunteers (NCT02665832) | Daewoong Pharmaceutical Co. LTD. | 2016-01-01 |
| Phase 1/1b Study to Evaluate the Safety and Tolerability of Ciforadenant Alone and in Combination With Atezolizumab in Advanced Cancers (NCT02655822) | Corvus Pharmaceuticals, Inc. | 2016-01-01 |
| Assessing the Role of a Fermented Soy Extract in Inflammation and the Human Microbiome (NCT02656056) | Yale University | 2016-01-01 |
| Changes in Speed, Endurance and Balance in Women Patients With Multiple Sclerosis After 4 & 8 Weeks of Aquatic Exercise Training (NCT02882724) | University of Isfahan | 2016-01-01 |
| Study of DS-1123a in Advanced Solid Tumours (NCT02690337) | Daiichi Sankyo Co., Ltd. | 2016-01-01 |
| A Drug Interaction Study to Assess the Effect of Omeprazole on the Pharmacokinetics of Ibrutinib in Healthy Adults (NCT02638116) | Janssen Research & Development, LLC | 2016-01-01 |
| A Phase 1b Study of Demcizumab Plus Pembrolizumab in Locally Advanced or Metastatic Solid Tumors (NCT02722954) | OncoMed Pharmaceuticals, Inc. | 2016-01-01 |
| Stem Cell Fistula Plug in Cryptoglandular Perianal Fistulas (MSC-AFP) (NCT02589119) | Mayo Clinic | 2016-01-01 |
| Evaluation of the Potential for Cytochrome P450 3A4 Inhibition by F901318 Using Oral Midazolam as a Probe (NCT02680808) | F2G Ltd | 2016-01-01 |
| A Phase 1/2 Study to Assess MultiStem® Therapy in Acute Respiratory Distress Syndrome (NCT02611609) | Healios K.K. | 2016-01-01 |
| A Perspective Multicenter Controlled Study On Application Of Mesenchymal Stem Cell(MSC) To Prevent Rejection After Renal Transplantation By Donation After Cardiac Death (NCT02490020) | Qipeng Sun | 2016-01-01 |
| NeuroRegen Scaffold™ Combined With Stem Cells for Chronic Spinal Cord Injury Repair (NCT02688049) | Chinese Academy of Sciences | 2016-01-01 |
| Lofexidine Pharmacokinetics in the Presence of Paroxetine in Healthy Volunteers (NCT02681198) | USWM, LLC (dba US WorldMeds) | 2016-01-01 |
| Autologous Immune Enhancement Therapy (AIET) for Cancer Patients (NCT05520372) | Vinmec Research Institute of Stem Cell and Gene Technology | 2016-01-01 |
| Apical Patency and Postoperative Pain. (NCT02768285) | Isparta Military Hospital | 2016-01-01 |
| Glucosamine Sulphate and Ginkgo Biloba as Antifungal Activity for Treating Tinea Pedis (NCT02882438) | Ahmed A. H. Abdellatif | 2016-01-01 |
| Comparative Study of the Pharmacokinetics and Bioequivalence of Two Flupentixol Formulations (NCT02660840) | H. Lundbeck A/S | 2016-01-01 |
| Phase 1 Open-label Study of TRX518 Monotherapy and TRX518 in Combination With Gemcitabine, Pembrolizumab, or Nivolumab (NCT02628574) | Leap Therapeutics, Inc. | 2016-01-01 |
| Study to Evaluate Systemic Bioavailability of Oral OTS167 in Healthy Adult Subjects (NCT02768519) | OncoTherapy Science, Inc. | 2016-01-01 |
| Study on Hyperthermic Intraperitoneal Chemotherapy After Resection of Pancreascarcinoma (NCT02863471) | University Hospital Tuebingen | 2016-01-01 |
| Study of SBP-101 in Pancreatic Cancer (NCT02657330) | Panbela Therapeutics, Inc. | 2016-01-01 |
| Evaluation of Fostamatinib in Patients With cGVHD After Allogeneic Stem Cell Transplant (NCT02611063) | Stefanie Sarantopoulos, MD, PhD. | 2016-01-01 |
| Umbilical Cord Mesenchymal Stem Cells Infusion for Diabetes Related Vascular Complications (NCT02834858) | Jie Shen | 2016-01-01 |
| A Drug Interaction Study in Healthy Participants to Assess the Effect of Rifampin on the Pharmacokinetics of JNJ-42847922 (NCT02661893) | Janssen Research & Development, LLC | 2016-01-01 |
| A Study on Pneumoconiosis Treated With Whole-lung Lavage Combined With Mesenchymal Stem Cells (NCT02668068) | Jianwu Dai | 2016-01-01 |
| TOP-TRIAL Safety of Not Flushing Non-used PORT-A-CATH® in Cancer Patients (NCT02492477) | Krankenhaus Barmherzige Schwestern Linz | 2016-01-01 |
| Elotuzumab in Autologous Stem Cell Transplantation (ASCT) and Lenalidomide Maintenance for Multiple Myeloma (NCT02655458) | Hearn Jay Cho | 2016-01-01 |
| Reducing Dexamethasone Around Docetaxel Infusion (NCT02776436) | Leiden University Medical Center | 2016-01-01 |
| Apatinib and Irinotecan Combination Treatment in Esophageal Squamous Cell Carcinoma (NCT02645864) | Peking University | 2016-01-01 |
| Study of the Effects of Intravenous Exenatide on Cardiac Repolarization (NCT02650479) | Intarcia Therapeutics | 2016-01-01 |
| Triple P for Parents of Children With a Diagnosis of Cancer (NCT02647684) | University of Manchester | 2016-01-01 |
| A Study of Weekly Subcutaneous Injections of SER-214 in Subjects With Parkinson's Disease (PD), to Determine the Safety, Tolerability and Pharmacokinetic (PK) Profile of SER-214 (NCT02579473) | Serina Therapeutics | 2016-01-01 |
| Mesenchymal Stem Cells Transplantation for Liver Cirrhosis Due to HCV Hepatitis (NCT02705742) | Saglik Bilimleri Universitesi Gulhane Tip Fakultesi | 2016-01-01 |
| First-in-Human Single and Multiple Dose of GLPG2222 (NCT02662452) | Lakefront Biotherapeutics NV | 2016-01-01 |
| Safety and Pharmacokinetics of Piperacillin-tazobactam Extended Infusion in Infants and Children (PIP-TAZO) (NCT02466438) | St. Justine's Hospital | 2016-01-01 |
| Point-of-Care RBC Washing to Prevent Transfusion-Related Pulmonary Complications (NCT02094118) | Mayo Clinic | 2016-01-01 |
| Systemic Sclerosis (SSc) Vasculopathy: Improved Clinical Monitoring and Treatment (NCT02530996) | VA Office of Research and Development | 2016-01-01 |
| Nivolumab With DC Vaccines for Recurrent Brain Tumors (NCT02529072) | Gary Archer Ph.D. | 2016-01-01 |
| Phlebotomy Study of Testosterone Undecanoate (NCT02670343) | Clarus Therapeutics, Inc. | 2016-01-01 |
| Muscle Fiber Fragment Treatment for Urinary Incontinence (NCT01953263) | Wake Forest University | 2016-01-01 |
| ASIS for GAMMAGARD in Primary Immunodeficiency (NCT02123615) | ASIS Corporation | 2016-01-01 |
| A Study to Assess CD19-targeted Immunotherapy T Cells in Patients With Relapsed or Refractory CD19+ B Cell Leukemia (NCT02672501) | Shanghai GeneChem Co., Ltd. | 2016-01-01 |
| TDENV PIV and LAV Dengue Prime-boost Strategy Using AS03B Adjuvant (NCT03110952) | U.S. Army Medical Research and Development Command | 2016-01-01 |
| Pharmacokinetic Study of Dexmedetomidine After Intra-nasal Dosing in Children (NCT02836431) | Children's Hospital Medical Center, Cincinnati | 2016-01-01 |
| A Study to Evaluate Safety and Health Benefits of Basis™ Among Elderly Subjects. (NCT02678611) | Elysium Health | 2016-01-01 |
| Photo-induction as a Means to Improve Cisplatin Delivery to Pleural Malignancies (NCT02702700) | Centre Hospitalier Universitaire Vaudois | 2016-01-01 |
| Anti-GD2 4th Generation CART Cells Targeting Refractory and/or Recurrent Neuroblastoma (NCT02765243) | Zhujiang Hospital | 2016-01-01 |
| Autologous Cell Therapy After Stroke (NCT00908856) | University of California, Irvine | 2016-01-01 |
| A PK Study to Evaluate PUR0200 and a Reference Product in Healthy Subjects (NCT02671825) | Pulmatrix Inc. | 2016-01-01 |
| Nebulized Analgesia for Laparoscopic Appendectomy Trial (NCT02624089) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2016-01-01 |
| Pharmacokinetic Study to Compare Absorption of Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler (NCT03073057) | Orion Corporation, Orion Pharma | 2016-01-01 |
| ASIS for Botox in Upper Limb Spasticity (NCT02074150) | li nguyen | 2016-01-01 |
| Immunotherapy Combination Study in Advanced Previously Treated Non-Small Cell Lung Cancer (NCT02460367) | NewLink Genetics Corporation | 2016-01-01 |
| Combination Margetuximab and Pembrolizumab for Advanced, Metastatic HER2(+) Gastric or Gastroesophageal Junction Cancer (NCT02689284) | MacroGenics | 2016-01-01 |
| Phase I Trial of CEA Specific AAV-DC-CTL Treatment in Stage IV Gastric Cancer (NCT02496273) | The First People's Hospital of Changzhou | 2016-01-01 |
| Effect of Activated Charcoal on Rivaroxaban Pharmacokinetics in Healthy Subjects (NCT02657512) | Centre Hospitalier Universitaire de Saint Etienne | 2016-01-01 |
| Study of HuMab-5B1 (MVT-5873) in Subjects With Pancreatic Cancer or Other Cancer Antigen 19-9 (CA19-9) Positive Malignancies (NCT02672917) | BioNTech Research & Development, Inc. | 2016-01-01 |
| NeuroRegen Scaffold™ With Bone Marrow Mononuclear Cells Transplantation vs. Intradural Decompression and Adhesiolysis in SCI (NCT02688062) | Chinese Academy of Sciences | 2016-01-01 |
| Localized Therapeutics for the Treatment of Gastrointestinal Disorders II (NCT02745678) | Stanford University | 2016-01-01 |
| A Study of Olaparib With Concomitant Radiotherapy in Locally Advanced/Unresectable Soft-tissue Sarcoma (NCT02787642) | Institut Bergonié | 2016-01-01 |
| Prevention of Catheter Associated Lower Urinary Infections Using the Oxys Indwelling Catheter (NCT02658903) | Oxys Medical AG | 2016-01-01 |
| Transcranial Direct Current Stimulation Associate to Constraint Induced Movement Therapy Over Premotor Cortex in Severe Stroke (NCT02628561) | Federal University of Paraíba | 2016-01-01 |
| An Euglycemic Clamp Trial to Evaluate Pharmacokinetics of Single Doses of BioChaperone Insulin Lispro in Healthy Japanese Subjects (NCT02660502) | Adocia | 2016-01-01 |
| Drug-Drug Interaction Study to Assess the Effects of Multiple-Dose Administration of K-877 on the Pharmacodynamics and the Pharmacokinetics of Multiple-Dose Administration of Warfarin in Healthy Adult Volunteers (NCT02719431) | Kowa Research Institute, Inc. | 2016-01-01 |
| Cross-over Study in Volunteers to Compare the Pharmacokinetics of Tiotropium Delivered From Test and Reference Products (NCT02676297) | Solventum US LLC | 2016-01-01 |
| Broccoli Sprout Dose Response: Bioavailability and Effects of Air Pollutants (NCT02656420) | Johns Hopkins Bloomberg School of Public Health | 2016-01-01 |
| Ublituximab for Acute Neuromyelitis Optica (NMO) Relapses (NCT02276963) | Johns Hopkins University | 2016-01-01 |
| A Single and Multiple Dose Study of AMAZ-02 to Evaluate Safety and Pharmacokinetics in Elderly Subjects (NCT02655393) | Amazentis SA | 2016-01-01 |
| A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP6294 Administered Intravenously or Subcutaneously in Healthy Young Male and Female Subjects (NCT02681861) | Astellas Pharma Europe B.V. | 2016-01-01 |